Glucocorticoids for the treatment of anaphylaxis

Evidence-Based Child Health

Volumn 8, Issue 4, 2013, Pages 1276-1294

  Choo, Karen Jui Lin ^a   Simons, F Estelle R ^b   Sheikh, Aziz ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Anaphylaxis ; drug therapy ; Glucocorticoids therapeutic use ; Humans

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; GLUCOCORTICOID; HYDROCORTISONE; METHYLPREDNISOLONE; PLACEBO; PREDNISONE; TRIAMCINOLONE;

ABDOMINAL PAIN; ANAPHYLAXIS; COUGHING; DIARRHEA; DYSPNEA; HEART PALPITATION; HUMAN; MORTALITY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SHOCK; SKIN; STRIDOR; THORAX PAIN; UNSPECIFIED SIDE EFFECT; VOMITING; WHEEZING;

ANAPHYLAXIS [*DRUG THERAPY]; GLUCOCORTICOIDS [THERAPEUTIC USE]; HUMANS;

ADOLESCENT; ANAPHYLAXIS; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; EPINEPHRINE; FEMALE; GLUCOCORTICOIDS; HISTAMINE H1 ANTAGONISTS; HUMANS; INFANT; MALE; PRACTICE GUIDELINES AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESUSCITATION;

EID: 84880337205     PISSN: None     EISSN: 15576272     Source Type: Journal    
DOI: 10.1002/ebch.1925     Document Type: Review

References (124)

1. Additional references
2. Alrasbi 2007
3. Alrasbi M, Sheikh A. Comparison of international guidelines for the emergency medical management of anaphylaxis. Allergy 2007;62:838-41. [MEDLINE: 17620061]
4. Anaphylaxis UK Guidelines
5. Working Group of the Resuscitation Council (UK). Emergency treatment of anaphylactic reactions. Guidelines for healthcare providers. http://www.resus.org.uk/pages/reaction.pdf. 2008.
6. Badger 2004
7. Badger NO, Butler K, Hallman LC. Excessive anticoagulation and anaphylactic after rechallenge with lepirudin in a patient with heparin induced thrombocytopenia. Pharmacotherapy 2004;24:1800-3. [MEDLINE: 15585446]
8. Begg 1994
9. Begg CB, Mazumdar M. Opening characteristics of a rank correlation test for publication bias. Biometrics 1994;50:1088-101. [MEDLINE: 7786990]
10. Bock 2001
11. Bock SA, Monoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. Journal of Allergy and Clinical Immunology 2001;107:191-3. [MEDLINE: 11150011]
12. Bock 2007
13. Bock SA, Munoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, 2001-2006. Journal of Allergy and Clinical Immunology 2007;119:1016-8. [MEDLINE: 17306354]
14. Brown 2001
15. Brown AFT, McKinnon D, Chu K. Emergency department anaphylaxis: a review of 142 patients in a single year. Journal of Allergy and Clinical Immunology 2001;108:861-6. [MEDLINE: 11692116]
16. Brown 2004
17. Brown SG. Clinical features and grading of anaphylaxis. Journal of Allergy and Clinical Immunology 2004;114:371-6. [MEDLINE: 15316518]
18. Brown 2006
19. Brown SGA, Mullins RJ, Gold MS. Anaphylaxis: diagnosis and management. Medical Journal of Australia 2006;185:283-9. [MEDLINE: 16948628]
20. Chin 2004
21. Chin SM, Fergurson JW, Bajurnows T. Latex allergy in dentistry. Review and report of case presenting as a serious reaction to latex dental dam. Australian Dental Journal 2004;49:146-8. [MEDLINE: 15497359]
22. Clark 2004
23. Clark S, Bock SA, Gaeta TJ, Brennar BE, Cydulka RK, Camargo CA. Multicenter study of emergency department visits for food allergies. Journal of Allergy and Clinical Immunology 2004;113:347-52. [MEDLINE: 14767453]
24. Clark 2005
25. Clark S, Long AA, Gaeta TJ, Camargo CA Jr Multicenter study of emergency department visits for insect sting allergies. Journal of Allergy and Clinical Immunology 2005;116:643-9. [MEDLINE: 16159637]
26. Confino-Cohen 2010
27. Confino-Cohen R, Goldberg A. Allergen immunotherapy-induced biphasic systemic reactions: incidence, characteristics, and outcome: a prospective study. Annals of Allergy and Asthma Immunology 2010;104:73-8. [MEDLINE: 20143649]
28. Decker 2008
29. Decker WW, Campbell RL, Luke A, St. Stauver JL, Weaver A, Bellolio MF, et al.The etiology and incidence of anaphylaxis in Rochester, Minnesota: A report from the Rochester Epidemiology Project. Journal of Allergy and Clinical Immunology 2008;112:1161-5. [MEDLINE: 18992928]
30. Douglas 1994
31. Douglas DM, Sukenick E, Andrade WP, Brown JS. Biphasic systemic anaphylaxis: an inpatient and outpatient study. Journal of Allergy and Clinical Immunology 1994;93:977-85. [MEDLINE: 8006319]
32. Egger 1997
33. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34. [MEDLINE: 9310563]
34. Ellis 2007
35. Ellis AK, Day JH. Incidence and characteristics of biphasic anaphylaxis: a prospective evaluation of 103 patients. Annals of Allergy, Asthma and Immunology 2007;98:64-9. [MEDLINE: 17225722]
36. Gaeta 2007
37. Gaeta TJ, Clark S, Pelletier AJ, Camargo CA. National study of US emergency department visits for acute allergic reactions, 1993 to 2004. Annals of Allergy, Asthma and Immunology 2007;98:360-5. [MEDLINE: 17458433]
38. Greenberger 2007
39. Greenberger PA, Rotskoff BD, Lifschultz B. Fatal anaphylaxis: postmortem findings and associated comorbid diseases. Annals of Allergy, Asthma and Immunology 2007;98:252-7. [MEDLINE: 17378256]
40. Gupta 2003
41. Gupta R, Sheikh A, Strachan DP, Anderson HR. Increasing hospital admissions for systemic allergic disorders in England: analysis of national admissions data. BMJ 2003;327:1142-3. [MEDLINE: 14615340]
42. Gupta 2007
43. Gupta R, Sheikh A, Strachan DP, Anderson HR. Time trends in allergic disorders in the UK. Thorax 2007;62:91-6. [MEDLINE: 16950836]
44. Higgins 2011
45. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available fromL www.cochrane-handbook.org.
46. Joint Task Force 2005
47. Joint Task Force on Practice Parameters. The diagnosis and management of anaphylaxis: an updated practice parameter. Journal of Allergy and Clinical Immunology 2005;115 Suppl:483-525. [MEDLINE: 15753926]
48. Kemp 2002
49. Kemp SF, Lockey RF. Anaphylaxis: a review of causes and mechanisms. Journal of Allergy and Clinical Immunology 2002;110:341-8. [MEDLINE: 12209078]
50. Korenblat 1999
51. Korenblat P, Lundie MJ, Dankner RE, Day JH. A retrospective study of epinephrine administration for anaphylaxis: how many doses are needed?. Allergy and Asthma Proceedings 1999;20:383-6. [MEDLINE: 10624495]
52. Lieberman 2005
53. Lieberman P. Biphasis anaphylactic reactions. Annals of Allergy, Asthma and Immunology 2005;95:217-26. [MEDLINE: 15753908]
54. Lieberman 2006
55. Lieberman P, Camargo CA, Bohike K, Jike H, Miller RL, Sheikh A, et al.Epidemiology of anaphylaxis: Findings of the ACCAI Epidemiology of Anaphylaxis Working Group. Annals of Allergy, Asthma and Immunology 2006;97:596-602. [MEDLINE: 17165265]
56. Lin 2008
57. Lin RY, Anderson AS, Shah SN, Nurruzzaman F. Increasing anaphylaxis hospitalizations in the first 2 decades of life: New York State, 1990-2006. Annals of Allergy, Asthma and Immunology 2008;101:387-93. [MEDLINE: 18939727]
58. McLean-Tooke 2003
59. McLean-Tooke AP, Bethune CA, Fay AC, Spickett GP. Adrenaline in the treatment of anaphylaxis: what is the evidence?. BMJ 2003;327:1332-5. [MEDLINE: 14656845]
60. Muraro 2007
61. Muraro A, Roberts G, Clark A, Eigenmann PA, Halken S, Lack G, et al.The management of anaphylaxis in childhood: position paper of the European Academy of Allergology and Clinical Immunology. Allergy 2003;62:857-71. [MEDLINE: 17590200]
62. Neugut 2001
63. Neugut AI, Ghatak AT, Miller RL. Anaphylaxis in the United States. An investigation into its epidemiology. Archives of Internal Medicine 2001;161:15-21. [MEDLINE: 11146694]
64. Orbach 2005
65. Orbach H, Katz U, Sherer Y, Shoenfeld Y. Intravenous immunoglobulin: adverse effects and safe administration. Clinical Reviews in Allergy and Immunology 2005;29:173-84. [MEDLINE: 16391392]
66. Peng 2004
67. Peng MM, Jick H. A population-based study of the incidence, cause and severity of anaphylaxis in the United Kingdom. Archives of Internal Medicine 2004;164:317-9. [MEDLINE: 14769628]
68. Poulos 2007
69. Poulos LM, Waters AM, Correll PK, Loblay RH, Marks GB. Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005. Journal of Allergy and Clinical Immunology 2007;120:878-84. [MEDLINE: 17931562]
70. Pumphrey 2000
71. Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clinical and Experimental Allergy 2000;30:1144-50. [MEDLINE: 10931122]
72. Pumphrey 2003
73. Pumphrey RS. Fatal posture in anaphylactic shock. Journal of Allergy and Clinical Immunology 2003;112:451-2. [MEDLINE: 12897756]
74. Pumphrey 2007
75. Pumphrey RSH, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, 1999-2006. Journal of Allergy and Clinical Immunology 2007;119:1018-9. [MEDLINE: 17349682]
76. RevMan 5.1
77. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1 for windows. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.
78. Sampson 1992
79. Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal food anaphylaxis in children. New England Journal of Medicine 1992;327:380-4. [MEDLINE: 1294076]
80. Sampson 2005
81. Sampson HA, Munoz-Furlong A, Bock SA, Schmitt C, Bass R, Chowdhury BA, et al.Symposium on the definition and management of anaphylaxis: summary report. Journal of Allergy and Clinical Immunology 2005;115:584-91. [MEDLINE: 15753908]
82. Sampson 2006
83. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, et al.Second symposium on the definition and management of anaphylaxis: summary report - Second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. Journal of Allergy and Clinical Immunology 2006;117:391-7. [MEDLINE: 16461139]
84. Schleimer 2008
85. Schleimer RP. Pharmacology of glucocorticoids in allergic disease. In: Adkinson NF Jr, Yunginger JW, Busse WW, Bochner BS, Holgate ST, Simons FER editor(s). Middleton's Allergy Principles and Practice. 7th Edition. St Louis: Mosby Inc, 2008:1549-74.
86. Scranton 2009
87. Scranton SE, Gonzalez EG, Waibel KH. Incidence and characteristics of biphasic reactions after allergen immunotherapy. Journal of Allergy and Clinical Immunology 2009;123:493-8. [MEDLINE: 19064282]
88. Sheikh 2001
89. Sheikh A, Alves B. Age, sex, geographical and socio-economic variations in admissions for anaphylaxis: analysis of four years of English hospital data. Clinical and Experimental Allergy 2001;31:1571-6. [MEDLINE: 11678857]
90. Sheikh 2007
91. Sheikh A, ten Broek VM, Brown SGA, Simons FER. H1-antihistamines for the treatment of anaphylaxis with and without shock. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD006160.pub2; MEDLINE: 17253584]
92. Sheikh 2008
93. Sheikh A, Hippisley-Cox J, Newton J, Fenty J. Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. Journal of the Royal Society of Medicine 2008;101:139-43. [MEDLINE: 18344471]
94. Sheikh 2008b
95. Sheikh A, Shehata YA, Brown SGA, Simons FER. Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock. Cochrane Database of Systematic Reviews 2008, Issue 4. [DOI: 10.1002/14651858.CD006312.pub2]
96. Simons 2002
97. Simons FER, Peterson S, Black CD. Epinephrine dispensing patterns for an out-of-hospital population: a novel approach to studying epidemiology of anaphylaxis. Journal of Allergy and Clinical Immunology 2002;110:647-51. [MEDLINE: 12373275]
98. Simons 2004a
99. Simons FER. First aid treatment of anaphylaxis to food: Focus on epinephrine. Journal of Allergy and Clinical Immunology 2004;113:837-44. [MEDLINE: 15131564]
100. Simons 2004b
101. Simons FER. Epinephrine (adrenaline) in the first-aid, out-of-hospital treatment of anaphylaxis. Anaphylaxis. Chichester: Wiley, 2004:228-47.
102. Simons 2004c
103. Simons FER. Advances in H1-antihistamines. New England Journal of Medicine 2004;351:2203-17. [MEDLINE: 15548781]
104. Simons 2006
105. Simons FER. Anaphylaxis, killer allergy: long-term management in the community. Journal of Allergy and Clinical Immunology 2006;117:367-77. [MEDLINE: 16461138]
106. Simons 2007
107. Simons FE, Sheikh A. Evidence-based management of anaphylaxis. Allergy 2007;62:827-9. [MEDLINE: 17620059]
108. Simons 2008
109. Simons FER. Anaphylaxis. 2008 Mini-primer on allergic and immunologic diseases. Journal of Allergy and Clinical Immunology 2008;121 Suppl:402-7. [MEDLINE: 18241691]
110. Simons 2009
111. Simons FER. Anaphylaxis: Recent advances in assessment and treatment. Journal of Allergy and Clinical Immunology 2009;124:625-36.
112. Smit 2005
113. Smit DV, Cameron PA, Rainer TH. Anaphylaxis presentations to an emergency department in Hong Kong: incidence and predictors of biphasic reactions. Journal of Emergency Medicine 2005;28:381-8. [PUBMED: 15837017]
114. Soar 2008
115. Soar J, Pumphrey R, Cant A, Clarke S, Corbett A, Dawson P, et al.Working Group of the Resuscitation Council (UK). Emergency treatment of anaphylactic reactions: guidelines for healthcare providers. Resuscitation 2008;77:157-69. [PUBMED: 18358585]
116. Stark 1986
117. Stark BJ, Sullivan TJ. Biphasic and protracted anaphylaxis. Journal of Allergy and Clinical Immunology 1986;78:76-83. [MEDLINE: 3722636]
118. Walters 2005
119. Walters BA, Van Wyck DB. Benchmarking iron dextran sensitivity: reactions requiring resuscitative medication in incident and prevalent patients. Nephrology, Dialysis, Transplantation 2005;20:1438-42. [MEDLINE: 15840683]
120. Webb 2006
121. Webb LM, Lieberman P. Anaphylaxis: a review of 601 cases. Annals of Allergy, Asthma and Immunology 2006;97:39-43. [MEDLINE: 16892779]
122. References to other published versions of this review
123. Choo 2010
124. Choo KJL, Simons FER, Sheikh A. Glucocorticoids for the treatment of anaphylaxis. Cochrane Database of Systematic Reviews 2010, Issue 3. [DOI: 10.1002/14651858.CD007596.pub2]